These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29496754)

  • 1. Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey.
    Lim DR; Dean AS; Taguinod-Santiago MR; Borbe-Reyes A; Cabibbe AM; Zignol M; Basilio RP; Garfin AMC; Ama MCG
    Eur Respir J; 2018 Mar; 51(3):. PubMed ID: 29496754
    [No Abstract]   [Full Text] [Related]  

  • 2. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
    Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based surveillance of extensively drug-resistant tuberculosis in Shandong Province, China.
    Li X; Wang H; Jing H; Wang Y; Yu C; Wang J; Liu Z; Graviss EA; Ma X
    Int J Tuberc Lung Dis; 2012 May; 16(5):612-4. PubMed ID: 22410186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone-resistant Mycobacterium tuberculosis, Pakistan, 2005-2009.
    Jabeen K; Shakoor S; Chishti S; Ayaz A; Hasan R
    Emerg Infect Dis; 2011 Mar; 17(3):564-6. PubMed ID: 21392465
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoroquinolone resistance in multidrug-resistant
    Che Y; Song Q; Yang T; Ping G; Yu M
    Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29217603
    [No Abstract]   [Full Text] [Related]  

  • 8. Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries.
    Ioannidis P; van Soolingen D; Mokrousov I; Papaventsis D; Karabela S; Konstantinidou E; Marinou I; Nikolaou S; Kanavaki S; Mantadakis E; Samonis G; Anthony R; Vogiatzakis E
    Clin Microbiol Infect; 2017 Dec; 23(12):1002-1004. PubMed ID: 28698038
    [No Abstract]   [Full Text] [Related]  

  • 9. First report of extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) infection in Kuwait.
    Mokaddas E; Ahmad S; Eldeen HS; Zaglul H; Al-Mutairi NM; Al-Otaibi A
    J Infect Public Health; 2021 Nov; 14(11):1612-1613. PubMed ID: 34624715
    [No Abstract]   [Full Text] [Related]  

  • 10. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-resistant tuberculosis plagues India.
    Sibbald B
    CMAJ; 2016 Mar; 188(5):322-324. PubMed ID: 26883311
    [No Abstract]   [Full Text] [Related]  

  • 12. Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa.
    Shah NS; Richardson J; Moodley P; Moodley S; Babaria P; Ramtahal M; Heysell SK; Li X; Moll AP; Friedland G; Sturm AW; Gandhi NR
    Emerg Infect Dis; 2011 Mar; 17(3):510-3. PubMed ID: 21392446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-extensively drug-resistant tuberculosis spondylodiscitis in an immunocompetent patient: a case report.
    Fellous S; Rkain H; Tahiri L; Bouraqadi A; Nassar I; Allali F
    Pan Afr Med J; 2020; 36():165. PubMed ID: 32952809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016.
    Mustazzolu A; Borroni E; Cirillo DM; Giannoni F; Iacobino A; ; Fattorini L
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29724919
    [No Abstract]   [Full Text] [Related]  

  • 16. What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
    Sharma SK; Dheda K
    Indian J Med Res; 2019 Mar; 149(3):309-312. PubMed ID: 31249191
    [No Abstract]   [Full Text] [Related]  

  • 17. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
    Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
    BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and Outlooks in Multi-drug Resistant Tuberculosis.
    Caminero Luna JA
    Arch Bronconeumol; 2017 Aug; 53(8):417-418. PubMed ID: 28314633
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
    Lai CC; Tan CK; Huang YT; Liao CH; Hsueh PR
    J Antimicrob Chemother; 2011 Oct; 66(10):2437-8. PubMed ID: 21798881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.